Harbour Investments, Inc. Gt Biopharma, Inc. Transaction History

Harbour Investments, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 16, 2022	SELL	$3.05 - $7.08 $305 - $708	-100 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$6.68 - $15.26 $113 - $259	-17 Reduced 14.53%	100 $1,000
Q2 2021 Aug 16, 2021	BUY	$7.19 - $18.96 $719 - $1,896	100 Added 588.24%	117 $2,000
Q1 2021 Aug 17, 2021	BUY	$4.4 - $8.84 $74 - $150	17 New	17 $0

564

Ticker GTBP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 32,557,700
Market Cap $96.4M
Description
GT Biopharma, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of immuno-oncology products based on its proprietary Tri-specific Killer Engager (TriKE) fusion protein immune cell engager technology platform. It develops GTB-3550, a single-chain tri-specific recombinant fusion protein conjugate th...

Get notified when there are updates to the investment portfolio of Harbour Investments, Inc., based on Form 13F filings with the SEC.

Stay updated on Harbour Investments, Inc. with notifications on news.